Related Experiment Video
Updated: Aug 10, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Carrier presentation: a possible strategy for selective in vivo amplification of specific T cells
H M Saxena1, R A Robins, R W Baldwin
1Cancer Research Campaign Laboratories, University Park, Nottingham, U.K.
Abstract:
A strategy for selective in vivo amplification of specific T cells by carrier presentation is outlined here. This hypothesis addresses the possible physiological significance of expression of MHC II molecules by T cells, and attempts to highlight the possibility of harnessing the phenomenon for therapeutic use in medicine.
More Related Videos
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
08:33Isolation, Cultivation, and Transient Transfection of Primary Human T Cells to Generate Chimeric Antigen Receptor (CAR) T Cells
Published on: March 27, 2026